PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Medical Affairs & Innovation, Héma-Québec, Montreal, QC, Canada.\', \'Microbiology, Canadian Blood Services, Edmonton, AB, Canada.\', \'Department of Medical Affairs, Sanquin Blood Supply Foundation, Amsterdam, Netherlands.\', \'Department of Clinical Immunology, Aarhus University Hospital, Aarhus, Denmark.\', \'Epidemiology & Surveillance, Canadian Blood Services, Ottawa, ON, Canada.\', \'School of Health and Behavioural Sciences, University of the Sunshine Coast, Petrie, QLD, Australia.\', \'Research & Scientific Programs, Vitalant, San Francisco, CA, USA.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1111/vox.13100
?:hasPublicationType
?:journal
  • Vox sanguinis
is ?:pmid of
?:pmid
?:pmid
  • 33914918
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.003
?:rankingScore_hIndex
  • 75
is ?:relation_isRelatedTo_publication of
?:title
  • An international comparison of anti-SARS-COV-2 assays used for seroprevalence surveys from blood component providers.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33914918>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33914918>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all